v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | IRCT20201024049134N4 |
Full text link
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
|
First author
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
|
Contact
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
rezaghadimi@yahoo.com |
Registration date
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
2021-10-21 |
Recruitment status
Last imported at : March 20, 2022, 9:39 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Completed |
Study design
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
RCT |
Allocation
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Randomized |
Design
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Parallel |
Masking
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Blind label |
Center
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
single-center |
Study aim
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Treatment |
Inclusion criteria
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Men and women of at least 18 years of age capable of providing informed consent Confirmation of COVID-19 with RT-PCR Need for hospitalization No need for mechanical ventilation No need to more than 10 L/min of supplemental oxygen by any device. The patient must meet at least one of the following high-risk criteria: age 70 years or older, obesity (BMI ≥ 30 kg/m2), diabetes mellitus, uncontrolled blood pressure (systolic blood pressure> 150 mm Hg), history of respiratory disease (Including asthma or COPD), history of heart failure, history of coronary artery disease, fever > 38.4°C in the last 48 hours, shortness of breath at the time of referral, Bicytopenia, Pancytopenia, or a combination of neutrophilia and lymphopenia |
Exclusion criteria
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
History of allergy to dimethyl fumarate Use of dimethyl fumarate before current hospitalization Patients more than 70 years of age with a history of any of the following in the last six months: Class III / IV Heart Failure Based on the New York Heart Association (NYHA) classification, Insulin-dependent diabetes, Angina pectoris, Malignancy Uncontrolled bacterial, fungal, or viral infection (other than COVID-19). Any history of receiving convalescent plasma therapy Absolute neutrophil count (ANC) < 500 Platelets count < 50,000 Pregnant women or those intending to become pregnant Breastfeeding women AST or ALT > 5 times the upper limits of normal (ULN) Estimated glomerular filtration rate (eGFR) < 30 ml/min in 1.73 m2 using MDRD equation |
Number of arms
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
2 |
Funding
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Babol University of Medical Sciences |
Inclusion age min
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
18 |
Inclusion age max
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
100 |
Countries
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Iran |
Type of patients
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Moderate/severe disease at enrollment |
Severity scale
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
4: Moderate/severe disease at enrollment |
Total sample size
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
30 |
primary outcome
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Need for mechanical ventilation Death Severely ill |
Notes
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
|
Phase
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Phase 2/Phase 3 |
Arms
Last imported at : Oct. 23, 2021, 5:06 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
[{"arm_notes": "", "treatment_id": 407, "treatment_name": "Dimethyl fumarate", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |